AI37691/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1996	2
1997	1
1998	2
1999	2
2001	2
2003	1
2005	1
2006	1
2012	2
2025	0

1

The role of T-cell costimulatory activation pathways in transplant rejection.

Sayegh MH, Turka LA. Sayegh MH, et al. N Engl J Med. 1998 Jun 18;338(25):1813-21. doi: 10.1056/NEJM199806183382506. N Engl J Med. 1998. PMID: 9632449 Review. No abstract available.

2

The in vivo mechanism of action of CTLA4Ig.

Judge TA, Tang A, Spain LM, Deans-Gratiot J, Sayegh MH, Turka LA. Judge TA, et al. J Immunol. 1996 Mar 15;156(6):2294-9. J Immunol. 1996. PMID: 8690920 Free PMC article.

3

Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.

Gupta S, Thornley TB, Gao W, Larocca R, Turka LA, Kuchroo VK, Strom TB. Gupta S, et al. J Clin Invest. 2012 Jul;122(7):2395-404. doi: 10.1172/JCI45138. Epub 2012 Jun 11. J Clin Invest. 2012. PMID: 22684103 Free PMC article.

4

TRAF6 is a critical factor for dendritic cell maturation and development.

Kobayashi T, Walsh PT, Walsh MC, Speirs KM, Chiffoleau E, King CG, Hancock WW, Caamano JH, Hunter CA, Scott P, Turka LA, Choi Y. Kobayashi T, et al. Immunity. 2003 Sep;19(3):353-63. doi: 10.1016/s1074-7613(03)00230-9. Immunity. 2003. PMID: 14499111 Free article.

5

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

Wells AD, Li XC, Li Y, Walsh MC, Zheng XX, Wu Z, Nuñez G, Tang A, Sayegh M, Hancock WW, Strom TB, Turka LA. Wells AD, et al. Nat Med. 1999 Nov;5(11):1303-7. doi: 10.1038/15260. Nat Med. 1999. PMID: 10545998

6

Quantifying the frequency of alloreactive T cells in vivo: new answers to an old question.

Suchin EJ, Langmuir PB, Palmer E, Sayegh MH, Wells AD, Turka LA. Suchin EJ, et al. J Immunol. 2001 Jan 15;166(2):973-81. doi: 10.4049/jimmunol.166.2.973. J Immunol. 2001. PMID: 11145675

7

CD28-B7 T cell costimulatory blockade by CTLA4Ig in the rat renal allograft model: inhibition of cell-mediated and humoral immune responses in vivo.

Akalin E, Chandraker A, Russell ME, Turka LA, Hancock WW, Sayegh MH. Akalin E, et al. Transplantation. 1996 Dec 27;62(12):1942-5. doi: 10.1097/00007890-199612270-00047. Transplantation. 1996. PMID: 8990393

8

Antibody-induced transplant arteriosclerosis is prevented by graft expression of anti-oxidant and anti-apoptotic genes.

Hancock WW, Buelow R, Sayegh MH, Turka LA. Hancock WW, et al. Nat Med. 1998 Dec;4(12):1392-6. doi: 10.1038/3982. Nat Med. 1998. PMID: 9846576

9

Site-specific accumulation of recently activated CD4+ Foxp3+ regulatory T cells following adoptive transfer.

Lieberman SM, Kim JS, Corbo-Rodgers E, Kambayashi T, Maltzman JS, Behrens EM, Turka LA. Lieberman SM, et al. Eur J Immunol. 2012 Jun;42(6):1429-35. doi: 10.1002/eji.201142286. Eur J Immunol. 2012. PMID: 22678899 Free PMC article.

10

The role of donor and recipient B7-1 (CD80) in allograft rejection.

Zheng XX, Sayegh MH, Zheng XG, Li Y, Linsley PS, Peach R, Borriello F, Strom TB, Sharpe AH, Turka LA. Zheng XX, et al. J Immunol. 1997 Aug 1;159(3):1169-73. J Immunol. 1997. PMID: 9233610

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year